NOVO NORDISK A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 875.30 DKK | -1.32% |
|
-5.62% | +25.38% |
| 09-10 | Health Care Up on Defensive Bias -- Health Care Roundup | DJ |
| 09-10 | Weight-loss market to see 16 new drugs by 2029, report estimates | RE |
EPS & Dividend: Novo Nordisk A/S
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 4.175 | 4.55 | 5.2 | 6.2 | 9.4 | 11.4 | 15.03 | 17.6 |
| Rate of return | 2.16% | 2.13% | 1.41% | 1.32% | 1.35% | 1.3% | 1.72% | 2.01% |
| EPS 2 | 8.19 | 9.005 | 10.37 | 12.22 | 18.62 | 22.71 | 28.89 | 34.4 |
| Distribution rate | 51% | 50.5% | 50.1% | 50.7% | 50.5% | 50.2% | 52% | 51.2% |
| Reference price 2 | 193.32 | 213.32 | 367.50 | 469.00 | 698.10 | 875.30 | 875.30 | 875.30 |
| Nbr of stocks (in thousands) | 4,703,720 | 4,624,923 | 4,557,801 | 4,517,704 | 4,458,288 | 4,433,564 | - | - |
| Announcement Date | 05/02/20 | 03/02/21 | 02/02/22 | 01/02/23 | 31/01/24 | - | - | - |
1DKK in Million2DKK
Estimates
Past dividends: Novo Nordisk A/S
| 14/08/2024 | Interim Payment 3.5 DKK |
| 21/03/2024 | Final Payment 6.4 DKK |
| 17/08/2023 | Interim Payment 6 DKK |
| 23/03/2023 | Final Payment 8.15 DKK |
| 11/08/2022 | Interim Payment 4.25 DKK |
| 24/03/2022 | Final Payment 6.9 DKK |
| 15/08/2021 | Interim Payment 3.5 DKK |
| 25/03/2021 | Final Payment 5.85 DKK |
| 13/08/2020 | Interim Payment 3.25 DKK |
| 26/03/2020 | Final Payment 5.35 DKK |
| 15/08/2019 | Interim Payment 3 DKK |
| 21/03/2019 | Final Payment 5.15 DKK |
| 16/08/2018 | Interim Payment 3 DKK |
| 22/03/2018 | Final Payment 4.85 DKK |
| 17/08/2017 | Interim Payment 3 DKK |
| 23/03/2017 | Final Payment 4.6 DKK |
| 11/08/2016 | Interim Payment 3 DKK |
| 20/03/2016 | Annual 6.4 DKK |
| 19/03/2015 | 5 DKK |
Upcoming events: Novo Nordisk A/S
More events
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| +1.30% | +1.72% | 38.54x | 27.01 | 13.43x | ||
| +0.58% | +0.67% | 58.11x | 40.04 | 18.01x | ||
| +2.80% | +3.07% | 21.43x | 5.704 | 4.63x | ||
| +3.13% | +3.24% | 38.8x | 42.14 | 7.32x | ||
| +2.67% | +2.80% | 15.38x | 5.957 | 4.89x | ||
| +1.91% | +2.02% | 28.97x | 5.972 | 5.21x | ||
| +3.66% | +3.76% | 16.05x | 5.952 | 3.81x | ||
| +3.24% | +3.35% | 21.08x | 5.292 | 4.99x | ||
| +2.79% | +3.01% | 50.67x | 35.23 | 6.84x | ||
| +5.60% | +5.71% | 21.83x | 1.922 | 3.73x | ||
| Average | +2.77% | +2.93% | 31.09x | 17.52 | 7.29x | |
| Weighted average by Cap. | +2.23% | +2.41% | 35.52x | 22.06 | 9.51x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition